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ABSTRACT 
Allograft inflammatory factor-1 (AIF-1) is a 17 kDa 
cytokine-inducible calcium-binding protein that in 
vertebrates plays an important role in allografts immune 
response and its expression is mostly limited to the 
monocyte/macrophage lineage. Recently it was assumed 
that AIF-1 was a novel molecule involved in inflammatory 
responses. To better clarify this aspect in the present 
study we investigated the expression of AIF-1 after 
bacterial challenge, wounds and tissue transplants and its 
potential role in regulating the innate immune response in 
an invertebrate model, the medicinal leech (Hirudo 
medicinalis). The analysis of an EST library from H. 
medicinalis CNS, revealed the presence of a gene, named 
Hmaif-1/alias Hmiba1, showing a high homology with 
vertebrate aif-1. Immunohistochemistry using an anti-
HmAIF-1 polyclonal antibody showed that this protein is 
constitutively present in spread, CD68+ macrophage-like 
cells. A few hours after pathogen bacterial injection in the 
body wall, the amount of these immunopositive cells 
increases at the injected site, co-expressing HmAIF-1 and 
the common leukocyte marker CD45. A similar overview 
was observed in the early stages of wound healing and in 
transplants, with many immunopositive cells around the 
lesion site or around the graft. Moreover, here we 
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demonstrated that the recombinant protein HmAIF-1 
induced a massive angiogenesis and it was a potent 
chemoattractant for macrophages. After rHmAIF-1 
stimulation, macrophage-like cells co-expressed the 
macrophage marker CD68 and the surface glycoprotein 
CD45, which in Vertebrates is involved in the integrin-
mediated adhesion of macrophages and plays a key role 
in regulating the functional responsiveness of cells to 
chemoattractants. We therefore hypothesized that CD45 
could play a role for leech macrophage-like cells activation 
and migration towards the inflammation site and we 
examined its potential effect on HmAIF-1-induced 
signaling.  
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INTRODUCTION 
Allograft Inflammatory Factor-1  
The Allograft Inflammatory Factor-1 (AIF-1), also called 
MRF-1, Iba1, daintain and IL-19, is a "calcium-binding 
protein" cytoplasmic cytokine of 17 kDa and 143 aa, IFN-
γ-inducible, with a Ca2+-binding EF-hand domain of 12 aa, 
and has been identified first in chronic rejection of rat 
cardiac allografts. In humans, AIF-1 is encoded within the 
HLA class III genomic region, located on chromosome 
6p21, moreover AIF-1-like factors, with aminoacid 
structure and with very well preserved functional role, 
have been described in other groups of metazoans. Data 
in literature have indeed shown that the expression of AIF-
1 increases significantly after transplantation, wounds or 
bacterial infections both in vertebrates (Utans et al., 1995; 
Deininger et al., 2000; Watano et al., 2001; Deininger et 
al., 2002; Autieri & Chen, 2005; Alkassab et al., 2007) and 
in invertebrates, such as Sponges (Kruse et al., 1999), 
Mollusks (de Zoysa et al., 2010; Zhang et al., 2011; Li et 
al., 2012b; Zhang et al., 2013) and Echinoderms (Ovando 
et al., 2012), suggesting that it could play a key role in the 
inflammatory response and in the immune system 
regulation. Its expression is in fact mainly associated with 
infiltrating macrophages in the allografts, inflammatory 
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lesions of central nervous system, tumors, bacterial 
infections and mechanical or biochemical vascular lesions 
(Deininger et al., 2000; Autieri & Carbone, 2001; Deininger 
et al., 2002; Autieri & Chen, 2005; Zhang et al., 2011; Li et 
al., 2012a; Ovando et al., 2012; Zhang et al., 2013; Drago 
et al., 2014). Furthermore, it appears to be closely related 
to vasculogenesis and angiogenesis and increases in a 
dose dependent manner the proliferation and migration of 
macrophages and endothelial cells. 
In particular AIF-1 expression was detected in cells 
expressing major histocompatibility complex class II 
molecules and in a subset of activated macrophages and 
microglial cells expressing MRP-8+ (macrophage-related 
protein-8), a Ca2+-sensing proteins whose translocation 
from the cytoplasm to the cellular membranes constitutes 
an indicator of activation and phosphorylation of 
macrophages (Beschorner et al., 2000). 
Since the release of AIF-1 is a Ca2+-dependent 
mechanism, it seems that AIF-1 may play a role in cell-cell 
interactions under inflammatory conditions (Tanaka & 
Koike, 2002). In particular, the ability to bind calcium 
allows to develop distinct pathways of signal transduction, 
protein expression and cell cycle regulation during the 
activation of macrophages and microglial cells. Therefore 
AIF-1 results to be a modulator of the immune response 
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during macrophage activation and tissue regeneration 
(Alkassab et al., 2007; Pawlik et al., 2008). 
Interesting to note is that AIF-1 shows the same 
functions and colocalizes with a leukocyte-specific 
member of the transmembrane PTPase family namely 
CD45, ubiquitously expressed on the surface of all 
nucleated cells of hematopoietic origin (Alkassab et al., 
2007; Sommerville et al., 2012; Jeong et al., 2013; Li et 
al., 2013). CD45 is a cell surface glycoprotein that, in 
vertebrates, is implicated in integrin-mediated adhesion of 
macrophages (Roach et al., 1997; Zhu et al., 2011; St-
Pierre & Ostergaard, 2013) and play a role in regulating 
the functional responsiveness of cells to chemoattractants 
(Roach et al., 1997; Mitchell et al., 1999), affecting the 
normal feedback mechanisms that are required to 
maintain adhesion and phagocytic activity. Indeed it has 
been reported that monocytes highly express AIF-1 and 
CD45, whereas resident microglia express AIF-1 but 
weakly and barely express CD45, confirming that both 
CD45 and AIF-1 might be involved in macrophage 
migration.  
Despite extensive investigation focused on both 
molecular characteristics and expression level of AIF-1 
during the inflammatory response or wound healing, the 
physiological role of this protein in the regulation of the 
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immune system is still not clear. In particular, it has 
previously reported that AIF-1 is a modulator of the innate 
immune response during macrophage activation (Utans et 
al., 1995; Alkassab et al., 2007), but the direct relationship 
between AIF-1 expression and macrophage 
activation/migration during the inflammation phase after 
injury or bacterial infection remains unclear, probably 
because the study of the immune response in Vertebrates 
appears to be a difficult challenge, primarily due to the 
complexity of these organisms. 
Choice of the experimental model and goal of the 
research  
We focused our research on the possible role of AIF-1 
during the immune response in an invertebrate model, the 
leech H. medicinalis (Annelida, Hirudinea), after challenge 
by bacterial pathogen, injury and grafts. Invertebrates, 
offering simpler systems, represent a great alternative. 
Indeed, basic steps of immune responses can be easily 
analyzed in leeches that might lack complex feed-back 
control systems typical of vertebrates (de Eguileor et al., 
2000b; de Eguileor et al., 2001; de Eguileor et al., 2003; 
de Eguileor et al., 2004; Grimaldi et al., 2006; Grimaldi et 
al., 2009; Schikorski et al., 2009; Grimaldi et al., 2011).  
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Experimental model 
The interest in using the leech as experimental model is 
linked to its anatomical and physiological features that 
allow to observe and study events linked to bacterial 
infection, wound healing and tissue repair (de Eguileor et 
al., 2003; de Eguileor et al., 2004; Tettamanti et al., 2004; 
Grimaldi et al., 2011). The cellular immune response, in 
particular, can be easily and unambiguously evaluated in 
leech’s body wall, which is a predominantly avascular 
muscular district containing a few immunocompetent cells 
of myeloid origin, i.e. macrophages, granulocytes and NK 
(de Eguileor et al., 1999). H. medicinalis is in fact 
characterized by the absence of a true vascular system 
within the muscular body wall and by the presence of two 
specific tissues: the botryoidal tissue, located close to the 
digestive system, involved in myeloerythroid and 
hematopoietic cells production and in the formation of new 
vessels, and the vasofibrous tissue, located more 
externally and involved in tissue regeneration after injury 
(Huguet & Molinas, 1994; Huguet & Molinas, 1996; 
Grimaldi et al., 2011) (Fig. 1).  
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Fig. 1: Transverse section of Hirudo. e: epithelium; m: longitudinal muscles; 
b: botryoidal tissue; vf: vasofibrous tissue 
The effects of bacterial challenge, lesion or grafts in the 
leech body wall are rapidly induced (24 hours) and can be 
studied by morphological and histochemical analyses. The 
inflammatory phase is characterized by an influx of 
macrophages that are responsible for phagocytosis and 
immune cytotoxicity and clean the stimulated area, and 
release various growth factors (de Eguileor et al., 1999; de 
Eguileor et al., 2000a, b; Grimaldi et al., 2006; Tettamanti 
et al., 2006). A second, proliferative phase consists of a 
process characterized by fibroplasia, with fibroblast 
migration into the wound and deposition of new collagen, 
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fibronectin and other matrix components (Tettamanti et al., 
2004; Tettamanti et al., 2005). This phase is also 
characterized by angiogenesis, with an active endothelial 
cell multiplication and sprouting of new vascular capillaries 
from parent vessels (de Eguileor et al., 2003; Tettamanti 
et al., 2003b; de Eguileor et al., 2004; Tettamanti et al., 
2006). In H. medicinalis, new vessels formation is a 
sequential process, involving an initial vasculogenic step, 
followed by angiogenesis. The new vessels act as a 
“piping” system to transfer precursors of 
immunocompetent cells into injured or bacterial 
challenged areas. After a transendothelial migration, these 
cells leave the circulating fluid, disperse in the surrounding 
connective tissue and differentiate in mature leukocytes 
that mediate inflammatory response (Grimaldi et al., 
2006). In addition our previous papers (de Eguileor et al., 
2000a, b; Grimaldi et al., 2004; Grimaldi et al., 2006) and 
a recent report (Macagno et al., 2010) indicated the 
existence in leech of several CDs (Cluster of 
Differentiation) proteins, commonly used as immune cell 
markers, similar to mammalian CDs. All these features 
allow easy detection and monitoring of immunocompetent 
cell migration and of the angiogenic process and the basic 
steps of immune responses can be easily analysed in 
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leeches that lack complex feedback control systems 
typical of Vertebrates.  
Moreover a gene showing high similarity with Vertebrate 
AIF-1, named HmIba1/alias HmAIF-1 (GenBank accession 
number KF437461), has been recently identified (Drago et 
al., 2014) and characterized in leech Central Nervous 
System (CNS). HmAIF-1 genomic sequence consists of 7 
exons and 6 introns, and the protein has a molecular 
weight of about 18 kDa. The aminoacid sequence 
presents an identity of 52% with the human AIF-1, and it 
shows a closer relationship with molluscan than with other 
metazoan AIF-1 molecules, as is expected on the basis of 
evolutionary proximity between Annelids and Mollusks 
(both Lophotrochozoan) (Drago et al., 2014). In addition a 
polyclonal antibody against HmAIF-1 and the recombinant 
protein has been developed by the Jacopo Vizioli’s group 
(University of Lille) with which we collaborate. 
Goal of the research 
In order to better understand the role of HmAIF-1 during  
the innate immune response of leech after bacterial 
challenging, wound healing and graft stimulations, we 
investigated the effects of the AIF-1 overexpression by 
recombinant HmAIF-1 protein injection and the tissue-
specific and temporal expression of HmAIF-1 after 
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injections of both symbiotic and pathogen bacteria, injuries 
and grafts.  
Immunohistochemistry and western blot studies will be 
performed to determine the localization and the 
modulation of this gene in leech. The presence of HmAIF-
1 in uninjured, bacteria challenged, experimentally injured 
and grafted tissues will be established using the specific 
rabbit anti-HmAIF-1 polyclonal antibody. Ultrastructural 
analysis at electron microscope, the acid phosphatase 
enzymatic histochemical reaction and 
immunohistochemical analysis using the polyclonal 
antibody anti-CD68 and anti-CD45 macrophage cell 
markers will be performed to characterize the cells 
involved in the immune response and expressing HmAIF-
1. 
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MATERIALS AND METHODS 
Animals and Treatments 
Leeches (Hirudo medicinalis, Annelida, Hirudinea, from 
Ricarimpex, Eysines, France) measuring 10 cm were kept 
in water at 20° C in aerated tanks. Animals were fed 
weekly with calf blood. Animals were randomly divided into 
separate experimental groups according to different 
protocols and treatments. Each treatment (bacterial or 
recombinant protein injections, wounds or tissue taking to 
be grafted) was performed at the level of the 20° segment. 
Before each experiment, leeches were anaesthetized with 
a 10% ethanol solution. Anesthetized leeches were then 
dissected and the body tissues were removed at specific 
time points after treatments. 
Group 1: uninjured control leeches to provide information 
on normal body organization.  
Group 2: (T6 h, T24 h, T48 h, T72 h, T7 days) control 
samples injected with 100 μl of sterilized phosphate buffer 
saline (PBS; 138 mM NaCl, 2.7 mM KCl, 4.3 mM 
Na2HPO4, 1.5 mM KH2PO4, pH 7.4).  
Group 3: (T24 h, T48 h, T72 h, T7 days) samples 
injected with 100 μl of sterilized PBS containing 20 ng of 
recombinant HmAIF-1 (rHmAIF-1) to functionally 
characterize cells migrating under the influence of this 
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factor. The best concentration of rHmAIF-1 required to 
induce significant cells migration was determined basing 
on our previous works on leeches (Tettamanti et al., 
2003b; Grimaldi et al., 2011). We tested three different 
concentrations (5 ng, 10 ng and 20 ng) and we obtained 
the best response with the higher amount.  
Group 4: (T24 h, T48 h, T72 h, T7 days) samples 
injected with 100 μl of sterilized PBS containing 20 ng of 
rHmAIF-1 pre-incubated 30 min at room temperature with 
1 μg of a specific polyclonal anti-HmAIF-1, raised in rabbit 
(New Zealand White, SPF) against a synthetic peptide 
corresponding to the predicted N-terminal region of the 
HmIba1 protein (Proteogenix, France) (Drago et al, 2014), 
to perform antibody-mediated neutralization experiments. 
Group 5: (T24 h) samples injected with 100 μl of PBS 
containing 20 ng of rHmAIF-1 pre-incubated 30 min at 
room temperature with 1 μg of pre-immune serum 
(1:20000) of the anti-HmAIF-1 antibody. 
Group 6: (T24 h) samples injected with 100 μl of PBS 
containing 20 ng of rHmAIF-1 pre-incubated 30 min at 
room temperature with 1 μg of polyclonal rabbit anti-CD45 
antibody (Twin Helix, Milano, Italy), to inhibit macrophage-
like cells responsiveness to rHmAIF-1.  
Group 7: samples injected with 100 μl of sterilized PBS 
containing respectively 100 ng/ml of LPS from E. coli 
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(Serotype 0111:B4, Sigma, St. Louis, MO, USA) or heat-
killed Gram-positive (Micrococcus nishinomiyaensis) and 
Gram-negative (Aeromonas hydrophila) bacteria (3X107 
CFU/ml) for immune stimulation assays. Bacteria were 
isolated from the natural environment of H. medicinalis. 
Challenged animals were sacrificed 6 h after injection and 
treated as indicated above.  
Group 8: (T24 h, T48 h, T72 h, T7 days) samples injured 
at about the 20° segment with a razor blade, in order to 
assess the modulation of HmAIF-1 during the wound 
healing.  
Group 9: (T24 h, T72 h, T7 days) samples used as hosts 
and donors for autografts and allografts. Surgical grafting 
was performed at the distal dorsal portion of leeches, 
about 2/3 from the oral extremity (at about the 20° 
segment): grafts were sutured with Dafilon® surgical 
synthetic monofilament (B. Braun) to avoid transplant loss 
due to contraction of the muscular body wall. Grafted 
leeches were kept in moist chambers for a post-surgical 
recovery period of 24 h, and subsequently placed in water 
tanks. The rate of successful transplantation experiments 
for all graft types was 90%. All leeches survived surgery 
and were able to move and feed following recovery from 
anesthesia. Autograft-bearing leeches: at about the 20° 
segment from the oral sucker, a block of 2mm×2mm×2mm 
 16 
 
was excised and afterwards replaced in the same hollow; 
allograft-bearing leeches: H. medicinalis host received a 
block of 2mm×2mm×2mm body wall excised from the 20° 
segment of a co-specific leech. Grafts were sutured with 
Dafilon® surgical synthetic monofilament (B. Braun) in 
order to avoid the transplant loss due to contraction of the 
body wall. 
Optical and Electron Microscopy 
Leech tissues, dissected from the area of the injection, 
the wound or the graft, were fixed for 2 h in 0.1 M 
cacodylate buffer at pH 7.4, containing 2% glutaraldehyde. 
Specimens were then washed in the same buffer and 
post-fixed for 1 h with 1% osmium tetroxide in cacodylate 
buffer, pH 7.4. After standard serial ethanol dehydration, 
specimens were embedded in an Epon-Araldite 812 
mixture. Sections were obtained with a Reichert Ultracut S 
ultratome (Leica, Wien, Austria). Semi-thin sections (0.75 
μm in thickness) were stained by conventional methods 
(crystal violet and basic fuchsine, according to Moore et 
al., 1960) and subsequently observed under the light 
microscope Nikon Eclipse Ni (Nikon, Tokyo, Japan). Data 
were recorded with a DS-5M-L1 digital camera system 
Nikon. Ultrathin sections (80 nm in thickness) were placed 
on copper grids, stained by uranyl acetate and lead citrate 
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and observed with a Jeol 1010 EX electron microscope 
(Jeol, Tokyo, Japan). Data were recorded with a MORADA 
digital camera system (Olympus, Tokyo, Japan). For 
immunogold cytochemistry, samples were fixed for 2 h 
with 4% paraformaldehyde and 0.5% glutaraldehyde in 
phosphate buffered saline (PBS), and then washed in the 
same buffer. After a standard step of serial ethanol 
dehydration, they were embedded in an Epon-Araldite 812 
mixture (Sigma, St. Louis, MO) and sectioned with a 
Reichert Ultracut S ultratome (Leica, Wien, Austria). 
Ultrathin sections (80 nm in thickness), after etching with 
NaOH 3% in absolute ethanol (Causton, 1984), were 
incubated for 30 min with PBS containing 2% bovine 
serum albumin (BSA) and then for 1 h with the primary 
rabbit anti-leech AIF-1 antibody (working dilution 1:50). 
Primary antibodies were visualized by immunochemical 
staining with secondary goat anti-rabbit IgG (H+L)-gold 
conjugate antibodies (GE Healthcare Amersham, 
Buckingamshire, UK) (particle size, 10 nm) diluted 1:40 
(incubation 30 min at room temperature). Control sections 
were incubated in saturation buffer and then with 
secondary antibodies alone. Samples were counterstained 
with uranyl acetate in water and observed with a Jeol 1010 
EX electron microscope (Jeol, Tokyo, Japan). Data were 
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recorded with a MORADA digital camera system 
(Olympus, Tokyo, Japan). 
Acid Phosphatase Reaction (ACP) 
Leech tissues, dissected from the area of the injection or 
wound, were embedded in Polyfreeze tissue freezing 
medium (OCT) (Polysciences, Eppelheim, Germany) and 
immediately frozen in liquid nitrogen. Cryosections (7 μm 
in thickness), obtained with a Leica CM 1850 cryotome, 
were rehydrated with PBS for 5 minutes, incubated with 
sodium acetate-acetic acid 0.1 M buffer for 5 minutes and 
then in the reaction mixture (sodium acetate-acetic acid 
0.1 M buffer, 0.01% naphtol AS-BI phosphate, 2% NN-
dimethylformamide, 0.06% Fast Red Violet LB and MnCl2 
0.5nM) for 90 minutes at 37°C. After washings in PBS, the 
slides were mounted with PBS/glycerol 2:1 and observed 
with the light microscope Nikon Eclipse Ni (Nikon, Tokyo, 
Japan). Images were taken with the digital camera Nikon 
Digital Sight DS-SM (Nikon, Tokyo, Japan). 
Indirect Immunofluorescence Staining 
Serial cryosections (7 μm in thickness) were stained by 
crystal violet and basic fuchsine for a morphological view 
or used for immunofluorescence staining. Sections, 
rehydrated with PBS for 5 minutes, were pre-incubated for 
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30 min with PBS containing 2% bovine serum albumin 
(BSA) before the primary antibody incubation (1 h at 
37°C). The primary antibodies used were: rabbit polyclonal 
anti-human CD45 (Twin Helix, Milano, Italy) which react 
with leech hematopoietic cells (de Eguileor et al., 2003) 
diluted 1:100, rabbit polyclonal anti-human CD68 (Santa 
Cruz Biotechnology) which react with leech macrophages 
(Grimaldi et al., 2006) diluted 1:100 and rabbit anti-
HmAIF-1 (Drago et al., 2014) diluted 1:1000. The use of 
antibodies generated against mammalian CD antigens to 
detect macrophages in leech is supported by several data 
from the literature on leeches (de Eguileor et al., 2000a, b; 
Grimaldi et al., 2004; Grimaldi et al., 2006) and on animals 
phylogenetically related to Annelids (Molluscs, 
Sipunculids) (Cossarizza et al., 1996; Blanco et al., 1997). 
The washed specimens were incubated for 1 h at room 
temperature with the appropriate secondary antibodies 
diluted 1:200 (Abcam®, Cambridge, UK): goat anti-rabbit 
FITC-conjugated (excitation 493 nm, emission 518 nm), 
goat anti-rabbit Cy3-conjugated (excitation 562 nm, 
emission 576 nm), goat-anti rabbit Cy5-conjugated 
(excitation 650 nm, emission 672 nm). Double labelling 
experiments were performed as already described 
(Grimaldi et al., 2009): a) to detect AIF-1, AIF-1/CD45 or 
AIF-1/CD68 the anti AIF-1 was applied first, then sections 
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were incubated with the secondary antibody goat anti-
rabbit FITC conjugated. After washing the cells were 
incubated with the antibody anti CD45 or anti CD68 and 
subsequently, with the secondary Cy5 conjugated goat 
anti-rabbit antibody; b) to detect CD45/CD68, the anti 
CD45 was applied first, then sections were incubated with 
the secondary Cy5 conjugated goat anti-rabbit antibody. 
After washing, the cells were incubated with the antibody 
anti CD68 and subsequently with the secondary antibody 
goat anti-rabbit FITC conjugated. Nuclei were stained by 
incubating for 15 min with 49,6-Diamidino-2-Phenylindole 
(DAPI, 0.1 mg/ml in PBS, excitation 340 nm, emission 488 
nm). The slides were mounted in Citifluor (Citifluor Ltd, 
London, UK) with coverslips and examined with a Nikon 
fluorescence microscope or with a confocal laser 
microscope (Leica TCS SP5). Images were combined with 
Adobe Photoshop (Adobe Systems, Inc.). 
In control samples, primary antibodies were omitted and 
sections were treated with BSA-containing PBS and 
incubated only with the secondary antibodies. 
Biochemical procedures 
H. medicinalis tissues from the unstimulated body wall or 
from injected or wounded areas were frozen in liquid 
nitrogen and then homogenized with a mortar. For SDS-
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polyacrylamide gel electrophoresis (SDS-PAGE), leech 
homogenates were suspended in extraction buffer 2X 
Laemmli's Buffer in the presence of a protease inhibitor 
cocktail (Sigma, Milan, Italy); the particulate material was 
removed by centrifugation at 13000 rpm for 10 min at 4°C 
in a refrigerated Eppendorf Minispin microcentrifuge. 
Supernatants were denatured at 100°C for 10 min.  
SDS-PAGE 
Proteins were separated in analytical SDS-PAGE using 
10% acrylamide minigels. Molecular weights were 
determined by concurrently running broad range 
standards from Bio-Rad (Bio-Rad, Richmond, MA, USA).  
Western Blot 
Proteins separated by SDS-PAGE were transferred onto 
Bio-Rad nitrocellulose filters. Membranes were then 
saturated with 5% non fat dried milk in Tris buffered saline 
(TBS, 20mM Tris-HCl buffer, 500mM NaCl, pH 7.5) at 
room temperature for 2 hr, and incubated for 90 minutes 
with a rabbit anti-leech AIF-1 antibody (1:5000 dilution in 
5% TBS-milk) or rabbit polyclonal anti-human CD45 IgG 
(Twin Helix) diluted 1:1000. After washing the membrane 
three times with TBS-Tween 0,1%, the antigens were 
revealed with the secondary anti-rabbit IgG antibody HRP-
conjugated (Jackson ImmunoResearch Laboratories, Inc., 
West Grove, USA), diluted 1:5000. After washing, the 
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immunocomplexes were revealed with luminol LiteAblot® 
PLUS Enhanced Chemiluminescent Substrate (EuroClone 
S.p.A., Pero, Italy).  
Bands were normalized, using the ImageJ software 
package (http://rsbweb.nih.gov/ij/download.html), with the 
housekeeping protein GAPDH, which were detected with a 
rabbit polyclonal anti-human GAPDH IgG (Proteintech™, 
Chicago, USA) diluted 1:2000. The expression level of 
HmAIF-1 in treated leeches was reported relatively to 
control uninjured animals. Experiments were performed in 
triplicate and data represent the mean values ± SEM. 
Statistical significance was assessed by an unpaired 
Student’s t test. 
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RESULTS 
The role of HmAIF-1 in immune response has been 
evaluated in leeches differently stimulated: 1) bacterial 
injection, 2) injury, 3) grafts, 4) injected with the 
recombinant protein rHmAIF-1.  
1) BACTERIAL INJECTIONS 
Ultrastructural and enzyme histochemical analyses in 
bacterial challenged leeches  
The uninjured leech body wall was essentially made up 
of an epithelium wrapping grouped muscle fibers 
embedded in a loose connective tissue. In normal 
uninjured body wall, few cells were observable immerse in 
the connective tissue surrounding the muscle fibers and 
underneath the epithelium (Fig. 1). 
The enzymatic histochemical assay highlighted, in M. 
nishinomiyaensis or LPS challenged leech body wall 
cryosections, numerous cells under the epithelium and 
among muscle fibers characterized by a strong positivity 
for the acid phosphatase (ACP) reaction (Fig. 2a, b), 
which level increased during phagocytosis process 
(Räisänen et al., 2001). By contrast, the ACP signal was 
reduced in PBS or A. hydrophila injected leeches (Fig. 2c). 
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Ultrastructural examination at TEM of immune-
challenged animals showed the presence of migrating 
macrophage-like cells among muscles fibers. A greater 
number cells was visible in tissues stimulated with the 
pathogen Gram-positive M. nishinomiyaensis or with LPS 
(Fig. 2d, e, g, h), compared to those stimulated with the 
symbiont Gram-negative bacterium A. hydrophila (Fig. 2f) 
or PBS-injected (Fig. 2i). The last tests were performed to 
unambiguously link the large increase in migrating cells 
with the immune activation of LPS and not with the 
injection of a solution.  
HmAIF-1 expression in uninjured and bacterial 
challenged leeches  
It has been previously reported that AIF-1 is significantly 
up-regulated in response to microbes infection both in 
vertebrates (Miyata et al., 2001; Wang & Wu, 2007) and in 
invertebrates (Zhang et al. 2011; Wang et al., 2013). To 
determine whether the same effect was visible in the 
leech, we performed immunohistochemical analysis using 
a specific HmAIF-1 antibody on cryosections from 
uninjured, PBS-injected or immune-challenged animals 
injected with the symbiont Gram-negative bacterium A. 
hydrophila, with the pathogen Gram-positive bacterium M. 
nishinomiyaensis or with LPS. Our data showed that 
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HmAIF-1 was constitutively expressed in uninjured 
animals (Fig. 3a-c). This factor was mainly expressed in 
cells located in the connective tissue underlying the body 
wall epithelium and surrounding the fields of muscle fibers. 
A similar pattern was observed in samples analyzed 6 
hours after PBS treatment, indicating that the mechanical 
stress induced by the injection or the vehicle solution 
alone did not exert a significant effect on HmAIF-1 
expression in the body wall of challenged animals (Fig. 3d-
f). Similarly, the injection of heat killed A. hydrophila 
appeared ineffective respect to the presence of HmAIF-1+ 
cells in the challenged area (Fig 3g-i). Interestingly, 6 
hours after M. nishinomiyaensis (Fig. 3j-l) or LPS injection 
(Fig. 3m-o), numerous cells were clearly recognizable in 
the challenged area. These cells were HmAIF-1+ and 
mainly localized under the epithelium and among the 
muscle fibers fields. No signal was detected in negative 
controls experiments where the primary antibody was 
substituted with the rabbit pre-immune serum (Fig. 3c) or 
where the primary polyclonal anti-HmAIF-1 antibody was  
omitted and sections were incubated only with the 
secondary antibody (Fig. 3f, i, l, o).  
The expression profile of HmAIF-1 in uninjured, PBS and 
bacterial challenged animals was confirmed by Western 
blot assay (Fig. 4). According to the results obtained on 
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leech CNS (Drago et al., 2014), immunoblotting analysis 
on body wall protein extracts confirmed the presence of an 
immune-reactive product at about 18 kDa (Fig. 4a). As 
observed in immunohistochemistry analysis, the amount of 
HmAIF-1 protein did not significantly change 6 hours after 
PBS or A. hydrophila injection respect to the basal 
expression level, but highly increased upon M. 
nishinomiyaensis or LPS challenge (Fig 4b). GAPDH was 
used as internal reference and bands intensity appeared 
homogeneously distributed in the loaded samples (Fig. 
4a). As previously reported (Drago et al., 2014), no 
specific signals were observed on the negative control 
experiments performed using primary rabbit pre-immune 
serum (data not shown). 
Double immunolocalization of HmAIF-1, leukocyte and 
macrophage markers in bacterial challenged leeches  
To better characterize the resident and migrating cells 
acid phosphatase positive and expressing HmAIF-1 
described above, we performed double-staining 
experiments coupling anti-HmAIF-1 to antibodies directed 
against the common human leukocytes marker CD45 and 
the specific human macrophage marker CD68 (Fig. 5). In 
PBS or A. hydrophila injected leeches, several HmAIF-
1+/CD45+ (Fig. 5a, e) or HmAIF-1+/CD68+ (Fig. 5b, f) and 
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CD45+/CD68+ (Fig. 5c, g) were more concentrated in the 
sub-epithelial area of the body wall, while among the 
muscle fibers a few resident immunocompetent cells 
HmAIF-1+/CD45+ (Fig. 5a, e) or HmAIF-1+/CD68+ (Fig. 5b, 
f) and CD45+/CD68+ (Fig. 5c, g) were visible. A higher 
amount of cells gathered at the challenged area was 
observed 6h after the treatment with M. nishinomiyaensis 
(Fig. 5i-k) or LPS (Fig. 5m-o). Numerous CD68+/CD45+ 
were visible underneath the epithelium and migrating 
among the muscle fibers (Fig. 5k, o). These cells also 
expressed HmAIF-1 (Fig. 5i, j, m, n) and it constitutes the 
first report of a macrophage-specific marker in leech. 
Moreover our data were in accordance with previous 
reports on Vertebrates (Trowbridge & Thomas, 1994; 
Roach et al., 1997), indicating that CD45 is implicated in 
macrophages differentiation, activation and migration.  
Control experiments performed in the absence of the 
anti-HmAIF-1 primary antibody (Fig. 5d, h) or with the pre-
immune serum (Fig. 5l, p), were negative for all the 
samples. 
The expression profile of CD45 in uninjured, PBS and 
bacterial challenged animals was also confirmed by 
Western blot assay (Fig. 6). Immunoblotting analysis on 
body wall protein extracts confirmed the presence of an 
immune-reactive product of 145 kDa (Fig. 6a). This 
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molecular weight corresponds to that of the murine 
counterparts. As observed in immunohistochemistry 
analysis, the amount of CD45 protein highly increased 
especially upon LPS challenge in respect to the basal 
expression level or 6 hours after PBS or A. hydrophila 
injection (Fig. 6b). As already described above, GAPDH 
was used as internal reference (Fig. 6a).   
2) WOUND HEALING 
Ultrastructural and enzyme histochemical analyses in 
wounded leeches  
As already described in previous works (Grimaldi et al., 
2004; Tettamanti et al., 2004; Grimaldi et al., 2006), 
following tissue damage, wound healing initiates with an 
inflammatory phase, characterized by a massive migration 
of immune cells, fibroblasts and myofibroblast-like cells 
towards the injured area. Wound repair and retraction was 
then obtained by the formation of a pseudoblastema 
region formed by the myofibroblast-like cells (Huguet & 
Molinas, 1994; Huguet & Molinas, 1996; Grimaldi et al., 
2009; Grimaldi et al., 2011). Analysis of injured tissues at 
TEM highlighted the presence of numerous macrophages 
like cells in the connective tissue close to the 
pseudoblastema region. These cells were highly positive 
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for ACP reaction, confirming their macrophage activity 
(Fig. 7a-h). 
HmAIF-1 expression in wounded leeches 
Sections of both uninjured, (Fig. 3a-c) and injured 
leeches analyzed after 24 h, 48 h, 72 h and 7 days from 
lesion (Fig. 8a-l), were immunostained with antibodies 
against HmAIF-1. Cells expressing HmAIF-1 were found 
dispersed in the extracellular matrix (ECM) surrounding 
the groups of muscle cells in the control uninjured animals 
(Fig. 3a-c) and close to the wound healing region of 
injured leeches (Fig. 8a-l). Our data showed that HmAIF-1 
expression dramatically increased in injured leeches, 
when a massive migration of cells towards the injured area 
was detectable (Fig. 8b, e, h, k). No signal was visible in 
negative controls experiments, in which primary antibody 
was omitted (Fig. 8c, f, i, l).  
Western blot assay was performed to assess the 
expression profile of HmAIF-1 in wounded leeches (Fig. 
9a, b). Compared to the basal expression level detected in 
uninjured leeches, the amount of HmAIF-1 protein 
significantly change in extracts of injured leech body wall, 
showing a peak of expression at 48 h from injury (Fig. 9b). 
GAPDH was used as internal reference (Fig. 9a).   
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Double immunolocalization of HmAIF-1, leukocyte and 
macrophage markers in wounded leeches 
Double immunofluorescent staining were then performed 
on cryosections of 24 h, 48 h, 72 h and 7 days injured 
leeches body wall using the following primary antibodies 
combination: HmAIF-1/CD45, HmAIF-1/CD68, 
CD45/CD68. Our data showed, in all sections, that the 
same cells expressing HmAIF-1 factor and dispersed in 
the ECM surrounding the groups of muscle fibers (Fig. 
10a, b) and close to the wound healing region (Fig. 10d, e) 
expressed also the common leukocyte marker CD45 and 
the macrophage cell markers CD68. Immunogold 
experiments confirmed the expression of HmAIF-1 in 
CD45+/CD68+ macrophage-like cells (Fig. 10g-i). 
Control experiments performed in the absence of the 
primary antibodies were negative for all the samples (Fig. 
10c, f).  
The expression profile of CD45 was analyzed by 
Western blot assay (Fig. 11a, b). Compared to the basal 
expression level detected in uninjured leeches, the 
amount of CD45 protein significantly change in body wall 
extracts of 48 and 72 h lesioned leech (Fig. 11b). GAPDH 
was used as internal reference and bands intensity 
appeared homogeneously distributed in the loaded 
samples (Fig. 11a). 
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3) GRAFTS 
HmAIF-1 expression in grafted leeches  
Our previous data demonstrated that self-transplantation 
caused no rejection but only an inflammatory response, 
whereas host Hirudo leeches rejected both allo- and 
xenografts (Tettamanti et al., 2003a). In this work, we 
focused on a possible role of HmAIF-1 in the rejection 
processes. Since H. medicinalis respond to allo- and 
xenografts in identical way, in terms of tissue reaction and 
cell populations involved, the results here presented were 
relative only to autografts and allografts experiments.  
Leech responses to autograft: the grafted area of 
leeches was characterized by an acute inflammatory 
reaction involving cell migration among fields of muscle 
fibers (Fig 12a). These migrating cells, morphologically 
and functionally already described as macrophage-like 
cells (Tettamanti et al., 2003b) positively stained for ACP 
reaction (Fig. 12b) and showed a low level of HmAIF-
1/CD45 expression (Fig. 12c, d).  
Leech responses to allograft: starting from 24 h after 
allograft, an acute inflammatory phase started with 
migrating immunocompetent cells. These cells, which 
migrated through the ECM, were involved in clot formation 
and in graft isolation from neighbouring tissues. In the 
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timespan of 7 days, non-self grafted tissue was completely 
surrounded and coated by host cells. Most of these cells 
were macrophages, which played a pivotal role with their 
phagocytotic activity directed to remove cell and matrix 
debris, positively stained for ACP reaction and highly co-
expressed CD45 and HmAIF-1 (Fig. 12e-g, i-k, m-o). No 
signal was detected in control negative experiments of 
immunolocalization, where primary antibody were omitted.  
4) rHmAIF-1 INJECTED LEECHES 
Morphological and enzymatic histochemical analyses of 
leech tissues injected with rHmAIF-1 
In order to assess the possible involvement of HmAIF-1 
in the regulation of H. medicinalis innate immune response 
and in particular in macrophage activation and migration, 
we evaluated the effects of the injection of the 
recombinant protein rHmAIF-1 in the leech body wall at 
different time points from treatment. At T24 h (Fig. 13d), 
T48 h (Fig. 13e) and T72 h (Fig. 13f) after rHmAIF-1 
injection, a large number of migrating cells, were readily 
recognizable among the muscle fibers. Interestingly, the 
migration of these cells was associated to an angiogenic 
process and to the appearance of a network of novel 
blood vessels in the space among the fields of muscle 
(Fig. 13d-f). After 7 days from injection (Fig. 13g), the 
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number of migrating cells was highly reduced, and only 
some vessels were still detectable under the epithelium. 
As observed by transmission electron microscopy (TEM) 
analysis, 48 hours after rHmAIF-1 injection (Fig. 13h), the 
entire body wall was heavily infiltrated by cells showing the 
typical features of leeches macrophages previously 
described (de Eguileor et al., 1999; de Eguileor et al., 
2000a). Neovessels, in which lumen-circulating cells were 
clearly recognizable, were also visible (Fig. 13i). As 
previously described (Grimaldi et al., 2006), these cells 
extravasated in the connective tissue and differentiate in 
mature leukocytes involved in innate immune response of 
leech. Extravasated hematopoietic precursors cells were 
in fact visible in the extracellular matrix surrounding the 
macrophages and muscle fibers (Fig. 13h).  
Function blocking experiments were performed by 
injecting the rHmAIF-1 pre-incubated with the specific anti-
HmAIF-1 polyclonal antibody (Fig. 13c). Results showed a 
reduced infiltration of cells and vessels among the groups 
of muscle fibers and under the epithelium, as well as for 
the PBS inoculation and for uninjured leeches (Fig. 13a, 
b). This confirmed the responsiveness of leech leukocytes 
and endothelial cells to HmAIF-1.  
The enzymatic ACP reaction confirmed the presence of a 
larger number of migrating cells with macrophage activity 
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in leeches injected with rHmAIF-1 (Fig. 14d, e) or both 
rHmAIF and pre-immune serum (Fig. 14f, g), in respect 
with control uninjured (Fig. 14a), PBS injected (Fig. 14b) 
and both rHmAIF and anti-HmAIF-1 injected leeches (Fig. 
14c).   
Double immunolocalization of HmAIF-1, leukocyte and 
macrophage markers in rHmAIF-1 injected leeches 
In order to characterize the cell types recruited at the site 
of rHmAIF-1 injection and to confirm our hypothesis that 
HmAIF-1 influences the mobilization of leech 
macrophages, double staining experiments were 
performed on cryosections of tissues collected 24 hours 
after injection using anti-HmAIF-1, anti-CD68 and anti-
CD45 antibodies. Both the experiments confirmed the 
accumulation of macrophage-like cells, positive for both 
CD45 and CD68, at the injection site of the recombinant 
protein (Fig. 15a). A large number of HmAIF-1/CD45 
positive cells, mainly distributed in the sub-epithelial 
region, were also visible in the injected area (Fig. 15b). 
This data indicated that rHmAIF-1 not only promoted the 
migration of CD45+/CD68+ macrophages, but also exerted 
a positive feedback effect on recruited cells inducing the 
expression of the factor. 
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Function blocking experiments showed a reduced 
number of macrophages co-expressing both the two 
markers CD45 and CD68 in the body wall of leeches 
injected with both the rHmAIF-1 and the anti-HmAIF-1 
(Fig. 15c). Furthermore, the number of cells expressing 
HmAIF-1 upon the same experimental conditions was 
highly reduced and the CD45+ cells were HmAIF-1 
negative (Fig. 15d), confirming a direct link between the 
injection of the recombinant protein and the induction of 
the factor in activated cells.  
Control experiments performed in the absence of primary 
antibodies were negative for all the samples (data not 
shown).  
Anti-CD45 polyclonal antibody treatment  
To determine a possible role of CD45 on macrophages 
responsiveness to HmAIF-1, we injected the rHmAIF-1 
together with the anti-CD45 antibody. Morphological (Fig. 
15e) and immunohistochemical analysis (Fig. 15f, g) 
showed that the anti-CD45 treatment inhibited the HmAIF-
1-induced responses described above, reducing the 
number of macrophages CD45+/CD68+ gathered at the 
injection site. In addition, double immunohistochemical 
experiments showed that CD45 expression was inhibited 
in the body wall of rHmAIF-1/anti-CD45 injected leeches 
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(Fig. 15f, g) and only a few resident macrophage CD68+ 
(Fig. 15f) and HmAIF-1+ (Fig. 15g) were still detectable, 
suggesting a direct role of CD45 in migration capability of 
the HmAIF-1-activated macrophages. 
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DISCUSSION 
In both invertebrates and vertebrates, inflammation is an 
acute reaction triggered by different types of lesions and 
aimed to fulfill two functions: a cytotoxic function to kill 
infected microbes and a repair function to regenerate 
damaged tissues. It is mediated by specific cells such as 
macrophages and neutrophils that infiltrate the damaged 
tissue, removing tissue debris and controlling invading 
microorganisms. These cells synthesize different 
molecules such as growth factors and cytokines, inducing 
mesenchymal cell recruitment in the injured or infected 
area (Jeong et al., 2013).  
In leeches as well proliferation and migration of immune 
cells are associated to important effects as angiogenesis 
and fibroplasia (Tettamanti et al., 2004; Grimaldi et al., 
2006) and in the present study we demonstrate that in the 
leech H. medicinalis the inflammatory factor HmAIF-1 is 
involved in the regulation of innate immune response by 
inducing angiogenesis and macrophages migration. Our 
results showed that, in leeches, the recombinant HmAIF-1 
has a strong chemotactic activity and in particular, it 
promotes macrophages and vessels migration towards the 
stimulated area, showing a similar function to AIF-1 of 
Vertebrates (Yamamoto et al., 2011). Moreover, here we 
show that in leeches, like in Vertebrates, this molecule is 
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constitutively expressed in untreated animals, but it is 
dramatically enhanced after microbial infection, 
mechanical injury or grafts.  
HmAIF-1 is expressed by leech macrophage-like 
cells 
Even if AIF-1 was originally cloned from active 
macrophages in human and rat atherosclerotic allogeneic 
heart grafts undergoing chronic transplant rejection (Utans 
et al., 1995), it has been later demonstrated that its 
transcripts were up-regulated in Vertebrates during 
macrophage and fibroblast migration (Yamamoto et al., 
2011), in wound healing and in angiogenesis (Autieri et al., 
2000; Autieri & Carbone 2001; Tian et al., 2009), both in 
Vertebrates and invertebrates in leukocytes upon LPS 
stimulation (Miyata et al., 2001; Zhang et al., 2011), and 
also in allograft rejection in sponges (Kruse et al., 1999). 
These results clearly suggest that AIF-1 could play a key 
role not only in different host responses to inflammatory 
stimuli, but also in the whole host immune defense 
reaction. We then hypothesized that HmAIF-1 could be 
involved in innate immune response in leeches as well 
and that its expression would be enhanced in a context of 
bacterial infections, wound healing and grafts. For this 
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reason, we performed LPS, A. hydrophila and M. 
nishinomiyaensis injections, surgical wounds and grafts.  
First of all we investigated the tissue-specific and 
temporal expression profile of HmAIF-1 factor after 
challenging by the environmental bacteria A. hydrophila, a 
Gram-negative bacterium present in bacterial flora where 
plays an essential role in the digestion of blood (Graf et 
al., 2006; Patel et al., 2013), and M. nishinomiyaensis, a 
Gram-positive bacterium pathogen for leeches (Schikorski 
et al., 2008). Finally, we also injected a 
lipopolysaccharides (LPS) solution, in order to test the 
effect on HmAIF-1 expression induced by a pathogenic 
Gram-negative bacterium infection. The action of LPS on 
leech tissues is well known and already described in 
previous works. Leeches pricked and injected with LPS 
showed a large amount of migrating CD68+ macrophages 
characterized by pseudopodia, phagolysosomes in their 
cytoplasm and a strong lysosomial activity (de Eguileor et 
al., 2000a, b).  
Leeches challenged with the M. nishinomiyaensis or 
stimulated with LPS showed a larger amount of migrating 
HmAIF-1+ cells than undamaged, PBS or A. hydrophila 
injected leeches. These assays, confirmed by western blot 
quantitative analysis, demonstrated that the increase in 
HmAIF-1+ and in CD45+ cells was caused by the immune 
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activation of LPS or Gram-positive bacterium challenge 
and not by the mechanical stress linked to the injection or 
to the presence of symbiont bacteria. The reason for the 
lower expression of CD45 than HmAIF-1 in M. 
nishinomiyaensis injected leeches could be explained by 
the greater efficacy against Gram-positive bacteria of the 
antimicrobial proteins in H. medicinalis saliva and tissues.  
Characterization of migrating cells was achieved by 
ultrastructural analysis, acid phosphatase reaction and 
immunohistochemistry using polyclonal antibodies 
directed against human macrophage and leukocytes 
markers CD68 and CD45. The use of antibodies 
generated against mammalian CD antigens to detect 
leukocytes and macrophages in leech is supported by 
several data from the literature on leeches (de Eguileor et 
al., 2000a; Grimaldi et al., 2004; Grimaldi et al., 2006) and 
on animals phylogenetically related to Annelids such as 
Molluscs and Sipunculids (Cossarizza et al., 1996; Blanco 
et al., 1997). Double-staining experiments highlighted that 
HmAIF-1+ cells co-expressed both CD45 and CD68. 
HmAIF-1 positivity indicated that this factor, as described 
for Mammals, is expressed in activated macrophages. It 
constitutes the first report of a macrophage-specific 
marker in leech. Numerous CD68+ and CD45+ 
macrophages were mainly detected in animals injected 
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with LPS or with the pathogen M. nishinomiyaensis. The 
ultrastructural morphology and acid phosphatase reaction 
positivity of migrating cells give further confirmation of the 
macrophage identity of migrating cells. It confirms that, like 
in Mammals, the immune challenge induces in leech body 
wall the migration and the accumulation of macrophage-
like cells at the injected site. Moreover, M. 
nishinomiyaensis and LPS caused remarkable 
inflammatory effects, inducing a massive angiogenesis 
and macrophages HmAIF-1+/CD45+/CD68+ migration. On 
the other hand, the effects of A. hydrophila were similar to 
those of PBS injection. These bacteria, being symbionts of 
leech digestive tract, probably did not induce a strong 
immune response even if injected in a different area of 
leeches body. The observed differences in reactivity to 
bacteria and LPS injections could be related to a different 
macrophage response induced by Gram-negative and 
Gram-positive bacterial infection. It is in fact known that 
leeches macrophages produce antimicrobial proteins and 
peptide, such as Hm-theromacin and destabilase, that 
cleave the cell wall components of Gram-positive bacteria 
digesting the β-1,4-glycosidic peptidoglycan links 
(Schikorski et al., 2008; Hildebrandt & Lemke, 2011), thus 
resulting more effective on Gram-positive than on Gram-
negative bacteria. Therefore, M. nishinomiyaensis may 
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cause lower cell migration than that caused by Gram-
negative.  
This immune challenge give rise to an overview 
consistent with that obtained after wounding (de Eguileor 
et al., 2003; Tettamanti et al., 2003b; Grimaldi et al., 2004; 
Grimaldi et al., 2006), in agreement with the fact that the 
wound healing process, in H. medicinalis, is enhanced by 
a controlled bacterial infection. It suggests that, in leech, 
the immune response is based on the same molecules 
involved in wound healing and regenerative process 
(Schikorski et al., 2008).  
Indeed, we found high level of HmAIF-1 expression in 
the tissue of injured and grafted leeches. In particular we 
noted a significant increase of HmAIF-1+ macrophage like 
cells migrating towards the injured area or forming a clot 
around the not-self tissue after 24-48 hours from surgery, 
while the expression level of this factor significantly 
decreases 7 days after injuries. Taken together, these 
findings suggest that besides cell-mediated defense 
reactions a cytokine-dependent immune response is also 
elicited during wound healing and graft recognition and 
rejection in leeches. 
Our results are in perfect agreement with what previously 
seen both in vertebrates (Autieri et al., 2000) and in 
invertebrates (Kruse et al., 1999; Zhang et al., 2011), 
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where a steady increase of HmAIF-1 was mainly detected 
in the initial stages of inflammation, 24-48 hours after 
surgery, and decline by 7-10 days after. Therefore, our 
data seem to confirm that, both in vertebrates and 
invertebrates, AIF-1 is involved in events that trigger 
inflammation more than in the progression of it (Autieri et 
al., 2000) and that this molecule has been highly 
evolutionarily conserved in both amino acid sequence and 
function. 
HmAIF-1 is involved in the recruitment and activation 
of leech macrophage-like cells  
The relationship between HmAIF-1 and the functional 
responsiveness of macrophages was assessed by 
injecting the recombinant factor in the body wall of 
leeches.  
We observed, 6 hours after rHmAIF-1 administration, the 
formation of an extensive vessel network spanning 
through the entire avascular body wall of the animal and 
the accumulation of numerous migrating cells localized 
among the fields of muscle fibers. Indeed, the injection of 
the recombinant protein together with a function blocking 
anti-HmAIF-1 antibody highly reduced angiogenesis and 
cells migration. Moreover, morphological analysis showed 
that macrophages recruitment induced by rHmAIF-1, was 
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higher in the first 48 hours from injection and decreased 
starting from 72 hours to 7 days after treatment. These 
data are in accordance with the reports from Vertebrates, 
where AIF-1 is implicated in macrophages activation at the 
early stages, rather than in late steps of the inflammatory 
process (Autieri et al., 2000; Deininger et al., 2000; 
Deininger et al., 2002; Zhang et al., 2011). In particular, 24 
hours after rHmAIF-1 injection, a high positivity to ACP 
reaction, as well as immunoreactive signal, was detected 
in the cytoplasm of migrating cells, mostly of which were 
CD68+ and CD45+ macrophages. In addition, the rHmAIF-
1 injection not only promoted the migration of 
CD45+/CD68+ macrophages, but also induced an 
enhancement of HmAIF-1 expression in the recruited 
cells. It suggests that macrophages, once chemoattracted 
in the stimulated area, express this factor to sustain the 
recruitment of further macrophages or to maintain their 
accumulation at the injured site. Despite of this positive 
feedback in HmAIF-1 expression, its mechanisms of 
action on target cells remains largely unexplored.  
The CD68+ macrophages co-express also the leukocyte 
common antigen CD45, sharing 55% identity with human 
CD45 (Macagno et al., 2010). Notably, this 
transmembrane glycoprotein in Vertebrates regulates 
integrin-mediated adhesion and is required to maintain 
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macrophage adhesion. Once macrophages adhere to the 
extracellular matrix, they mature and respond to 
environmental stimuli (Roach et al., 1997). Our data 
showed that the injection of rHmAIF-1 pre-incubated with 
specific anti-HmAIF-1 antibody reduced the number of 
migrating macrophages, most of which do not longer co-
express the CD45 and CD68 markers, unlike what is 
observed with pre-immune serum. Since it has been 
reported that CD45 regulates chemokine receptor 
expression in myeloid leukocytes and that it can modulate 
leukocyte traffic by regulating responses to chemokines 
(Mitchell et al., 1999), we hypothesize that CD45 
expression in leech might be implicated in maturation and 
functional responsiveness of macrophages to HmAIF-1. 
Indeed, the injection of the rHmAIF-1 together with the 
anti-CD45 polyclonal antibody reduced the macrophages 
migration. Although further experiments will be necessary, 
this result let hypothesize that the recruitment of 
macrophages is induced by a close interaction between 
HmAIF-1 and CD45 protein expressed at the surface of 
responsive cells, as indicated by previous work on 
Vertebrates (Yamamoto et al., 2011).  
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Concluding remarks 
Results here presented show that the expression of the 
HmAIF-1 significantly increases during the early phases of 
the inflammatory response and it is mainly exerted by 
activated macrophages. We demonstrate for the first time 
that HmAIF-1 is not only a potent angiogenic factor, but 
also a potent chemoattractant for macrophages. During 
bacterial infections, wound healing and grafts rejection 
HmAIF-1 might be implicated in the activation of these 
migrating cells, which role is to clean up the area from 
bacteria and damaged tissue, and to isolate the not-self 
grafts from the surrounding tissues. These processes are 
probably linked to the interaction between HmAIF-1 and 
CD45 to promote the integrin-mediated adhesion of 
macrophages to the extracellular matrix. Taken together 
these data indicate that leeches, sharing with vertebrates 
several morphofunctional and molecular mechanisms, can 
be considered a simple model useful to elucidate the role 
of AIF-1 in immune response, wound healing and graft 
rejection. 
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Fig. 2: Acid phosphatase reaction and TEM analysis of 
cryosections and ultra-thin sections from H. medicinalis 
immune challenged by injection of M. nishinomiyaensis (a, 
d, g), LPS (b, e, h) and A. hydrophila (c, f, i). Numerous 
ACP positive macrophages cells (arrowheads) were 
visible among the muscular fibers (M) and underneath the 
epithelium (E) in M. nishinomiyaensis (2a) and LPS (2b) 
injected leeches. In A. hydrophila (c) injected animals a 
few ACP positive cells are detected. (d-i) Detail at TEM of 
macrophages migrating toward the epithelium (d, e, g, h) 
and in the extracellular matrix surrounding muscle fibers 
(f, i). Bar in a: 100 m; bars in b, c: 50m; bars in d, g, h, 
i: 2m; bars in e, f: 5m 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3: Morphological (optical microscopy) and 
immunohistochemical (fluorescence microscopy) analysis 
of cryosections from H. medicinalis body wall uninjured (a-
c), PBS injected (d-f) or immune challenged by injection of 
A. hydrophila (g-i), M. nishinomiyaensis (j-l) and LPS (m-
o). Arrowheads indicate the population of resident and 
migrating immune-responsive cells located under the 
epithelium (E) and among the muscular fibers (M). 
Immunohistochemistry was performed using a rabbit 
polyclonal anti-HmAIF-1 antibody (red); nuclei were 
counterstained with DAPI (blue). Negative control 
experiments were performed with primary anti-HmAIF-1 
pre-immune serum (c) or secondary antibody alone (f, i, l, 
o). Bars in a-i: 100 m; bars in j-o: 50m 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4: Western blot analysis. (a) Protein extracts of 
uninjured (U), PBS, A. hydrophila (A), M. nishinomiyaensis 
(M) and LPS injected leeches body walls were probed with 
the anti-HmAIF-1 antibody. The housekeeping protein 
GAPDH was used as a loading control. In all the samples, 
the anti-HmAIF-1 detected specific immunoreactive bands 
of about 18 kDa, according to the molecular weight ladder. 
(b) HmAIF-1 protein was quantified by densitometry from 
three experiments. *p< 0.05 compared with uninjured 
leeches. 
 
  
 
 
 
 
 
 
 
 
 
 
 
Fig. 5: Double immunolocalization of HmAIF-1 and 
macrophages markers on cryosections of control PBS 
injected (a-c) and bacterial challenged (e-o) leech body 
wall. After 6 h from M. nishinomiyaensis or LPS injection, 
numerous HmAIF-1+/CD45+, HmAIF-1+/CD68+, 
CD68+/CD45+ macrophages (in yellow), migrating towards 
the injected area, are detectable under the epithelium (E) 
and among the muscle fibers (M). Double immunostaining 
was performed with anti-HmAIF-1 (green) and anti-CD45 
(red) or anti-CD68 (red in b, f, j, n; green in c, g, k, o) 
antibodies. (d, h, l, p). No signal were detected in negative 
control experiments where primary antibodies were 
omitted (d, h) or performed with primary anti-HmAIF-1 pre-
immune serum (l, p). Bars in a-d: 100 m; bars in e-i, k-m, 
o, p: 50m; bars in j, n: 25m 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 6: Western blot analysis. (a) Protein extracts of 
uninjured (U), PBS, A. hydrophila (A), M. nishinomiyaensis 
(M) and LPS injected leeches body walls were probed with 
the anti-CD45 antibody. The housekeeping protein 
GAPDH was used as a loading control. In all the samples, 
the anti-CD45 detected specific immunoreactive bands of 
about 145 kDa, according to the molecular weight ladder. 
(b) CD45 protein was quantified by densitometry from 
three experiments. *p< 0.05 compared with uninjured 
leeches.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7: Acid phosphatase reaction and TEM analysis on 
cryosections and ultra-thin sections from H. medicinalis 
body wall surgically wounded and analyzed after at 24 h 
(a, b), 48 h (c, d), 72 h (e, f) and 7 days (g, h) from injury. 
Numerous macrophages ACP positive are visible 
migrating among muscles (M) under the epithelium (E) 
and close to pseudoblastema (P). Bars in a, c, e, g: 
100m; bar in b: 4m; bars in d, f, h: 2m 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8: Morphological (optical microscopy) and 
immunohistochemical (fluorescence microscopy) analysis 
of cryosections from H. medicinalis body wall surgically 
wounded and analyzed after 24 h (a-c), 48 h (d-f), 72 h (g-
i) and 7 days (j-l) from injury. Numerous migrating cells 
(arrowheads) among muscle fibers (M) and close to the 
pseudoblastema (P) were visible. Immunohistochemistry 
using the rabbit polyclonal anti-HmAIF-1 antibody marks 
the HmAIF-1+ cells, in active migration towards the injured 
area (arrows). Nuclei were counterstained with DAPI 
(blue). No signal is detected in control experiment where 
the primary antibody was omitted (c, f, i, l). Bars in a-l: 
100 m 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Fig. 9: Western blot analysis. (a) Protein extracts of 
uninjured (U) and injured leeches after 24 h, 48 h, 72 h and 
7 days from injury were probed with the anti-HmAIF-1 
antibody. The housekeeping protein GAPDH was used as 
a loading control. In all the samples, the anti-HmAIF-1 
detected specific immunoreactive bands of about 18 kDa, 
according to the molecular weight ladder. (b) HmAIF-1 
protein was quantified by densitometry from three 
experiments. *p< 0.05 compared with uninjured leeches. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10: After injury numerous migrating macrophages 
(in yellow) located among muscle fibers (a, b) and close to 
the pseudoblastema (P) region (d, e) are CD45+/AIF-1+ 
and CD68+/AIF-1+. (c, f): negative control experiments 
where the primary antibodies are omitted. (g-i): 
immunogold staining confirms the expression of AIF-1, 
CD45 and CD68 in macrophages cells. Bars in a-c: 20 m; 
bars in d-f: 50 m; bar in g: 100 nm; bars in h, i: 500 nm 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
   
Fig. 11: Western blot analysis. (a) Protein extracts of 
uninjured (U) and injured leeches at 24 h, 48 h, 72 h and 7 
days were probed with the anti-human CD45 antibody. In 
all the samples, the anti-CD45 detected specific 
immunoreactive bands of about 145 kDa, according to the 
molecular weight ladder. The housekeeping protein 
GAPDH was used as a loading control. (b) CD45 protein 
was quantified by densitometry from three experiments. 
**p< 0.01 compared with uninjured leeches. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 12: Morphological (optical microscopy) 
histochemical enzymatic and immunohistochemical 
(fluorescence microscopy) analyses of cryosections from 
grafted H. medicinalis. Starting from 24h from autograft (a-
d) a clot of ACP positive macrophages cells (b) surround 
graft (G). These cells weakly express AIF1 and CD45 (c, 
d). Starting from 24h after allograft (e, i, m), the clot of 
ACP positive macrophages (f, j, n) highly co-expressed  
HmAIF-1 and CD45 (g, k, o). No signal is detected in 
control experiment where the primary antibodies are 
omitted (h, l, p). Bars in a-c: 50 m; bars in d, e, g, m-p: 
200 m; bars in f, h-l: 100 m 
 
  
 
 
 
 
 
 
 
 
Fig. 13: Morphological analysis of leech body wall 
uninjured (a), injected with PBS (b), with both rHmAIF-1 
and function blocking anti-HmAIF-1 antibody (c) or after 
injection of rHmAIF-1 (d-i). After 24 h (d) and 48 h (e) 
numerous neo-vessels (arrows) and migrating cell 
(arrowheads) are visible among muscles (M) and under 
the epithelium (E). (g) After 7 days from rHmAIF-I 
injection, vessels (arrows) are still visible in the leech body 
wall. (h) Detail at TEM of macrophages (arrowheads) and 
extravasated hematopoietic precursors cells (arrow) 
localized in the extracellular matrix (ECM) surrounding the 
muscle fibers (M). (i) Image at TEM of hematopoietic 
precursors cells (arrowhead) in the lumen of a neo-vessel 
(arrow). (a-c) In uninjured or after 24 h from PBS or 
rHmAIF-1 + anti-HmAIF-1 antibody injection, a reduced 
infiltration of cells and vessels among the groups of 
muscle fibers (M) and under the epithelium (E) is evident. 
Bars in a-g: 100 m; bar in h: 2m; bar in i: 400 nm 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 14: ACP reaction on cryosections from uninjured (a), 
injected with PBS (b), with both rHmAIF-1 and function 
blocking anti-HmAIF-1 antibody (c), after injection of 
rHmAIF-1 (d, e) or after injection of rHmAIF-1 + pre-
immune serum (f, g). After 24 h and 48 h from rHmAIF-1 
(d, e) or from rHmAIF-1 + pre-immune serum mixture 
injection (f, g), numerous migrating cell (red) are visible 
among muscles (M) and under the epithelium (E). (a-c) In 
uninjured or after 24 h from PBS or rHmAIF-1 + anti-
HmAIF-1 antibody injection, a reduced infiltration of ACP 
positive cells among the groups of muscle fibers (M) and 
under the epithelium (E) is evident. Bars in a-d, f: 100 m; 
bars in e, g: 200m 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 15: (a, b) 24 h after rHmAIF-1 injection numerous 
migrating macrophages (in yellow) are double stained by 
the antibodies CD45 and CD68 and are CD45+/AIF-1+. (c, 
d) After 24 h from the injection of the rHmAIF-1 + anti-
HmAIF-1 mixture, a few activated macrophages co-
expressing CD45 (red in c) and CD68 (green in c) or 
CD45 (red in d) and HmAIF-1 (green in d) are visible. (e-
g) After the injection of the antibody anti-CD45 together 
with the rHmAIF-1 only a few macrophages (arrowheads 
in e) CD45-/CD68+ (f) are visible underneath the 
epithelium (E) and among muscles (M). (g) The antibody 
anti-CD45 injection inhibits the CD45 expression and the 
few resident macrophages are CD45-/AIF-1+. Bars in a-g: 
50 m 
 
